Skip to content

Home
About us
Service
- Pharmaceutical Clinical Trials
- Medical Device Clinical Trials
Industry Insights
English

Quotation Request

Home
About us
Service
- Pharmaceutical Clinical Trials
- Medical Device Clinical Trials
Industry Insights
English

Quotation Request

인투인월드
2024/02/29
Newsletter_EN

[Newsletter] Vol 48. Feb 2024

HomeNewsletter_EN[Newsletter] Vol 48. Feb 2024

Newsletter Vol 48. This is the February 2024 newsletter.

Newsletter-Vol.48-1 Download

Related Posts

[Newsletter] Vol 74. April 2026

2026/04/16

[Newsletter] Vol 73. March 2026

2026/03/20

[Newsletter] Vol 72. February 2026

2026/02/26

[Newsletter] Vol 71. January 2026

2026/01/23

1 2 3 … 11 Next >

New Posts

The 2026 Paradigm Shift in Genetic Medicines: Accelerating the In Vivo CAR-T Pipeline and Global Clinical Trials Operating Strategies 2026/04/30

Pan-RAS Inhibitor Payload ADC Trend (2026): What AACR 2026 Signals for Clinical Design, Safety, and CMC 2026/04/23

[Newsletter] Vol 74. April 2026 2026/04/16

Clinical Trials Playbook 2026: Global CRO Operating System 2026/04/14

Korea Clinical Trial Start-up Timeline (2026) 2026/04/08

1 2 3 … 25

Business registration number

425-87-00267

Tel

+82-2-2038-8082

E-mail

intoin@intoinworld.com

CEO

John Choi

Address

10F, 21, Gukhoe-daero 62-gil, Yeongdeungpo-gu, Seoul, 07236, Korea

Privacy Policy
Terms of Service
Email Collection Prohibited

COPYRIGHT © INTOINWORLD, ALL RIGHT RESERVED

When selecting a CRO partner, which factor matters most to you?Referral / a CRO I already knowProven experience in our therapeutic areaBudget transparencySpeed and operational responsiveness (fast start-up, quick issue resolution)Other (please specify)